Rainmed Medical Limited
HKSE: 2297.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Yonghui Lyu
- Employees
- 270
- Headquarters
- Suzhou, China
- IPO year
- 2022
- Market cap
- HK$334.9M
- Website
- https://rainmed.com
Loading 2297…
Loading profile data…Frequently asked questions about 2297
What does Rainmed Medical Limited (2297.HK) do?
Rainmed Medical Limited, a medical device company, focus on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microvascular resistance systems. The company offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve m...
Where does 2297.HK trade?
Rainmed Medical Limited (2297.HK) trades on the Hong Kong Stock Exchange.
What sector is 2297.HK in?
Rainmed Medical Limited (2297.HK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Rainmed Medical Limited?
Yonghui Lyu is the chief executive officer of Rainmed Medical Limited (2297.HK).
Where is Rainmed Medical Limited headquartered?
Rainmed Medical Limited is headquartered in China.
Does 2297.HK pay a dividend?
Rainmed Medical Limited (2297.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2297.HK go public?
Rainmed Medical Limited (2297.HK) completed its initial public offering in 2022.